Biolife Solutions (BLFS) Assets Average (2011 - 2026)

Biolife Solutions (BLFS) has reported Assets Average for 16 consecutive years, with $424.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average rose 8.44% year-over-year to $424.2 million in Q2 2026; TTM through Jun 2026 was $424.2 million, a 8.44% increase from a year earlier, with the FY2025 full-year figure at $402.7 million, down 0.84% from the prior year.
• Assets Average was $424.2 million for Q2 2026 at Biolife Solutions, up from $403.4 million in the prior quarter.
• Over five years, Assets Average peaked at $549.3 million in Q1 2022 and troughed at $378.3 million in Q3 2024.
• A 5-year average of $427.6 million and a median of $409.5 million in 2023 frame the typical range for Assets Average.
• Across the five-year window, Assets Average surged 131.35% in 2022 and dropped 18.38% in 2023, its largest moves.
• Over 5 years, Assets Average stood at $469.1 million in 2022, then decreased by 12.19% to $411.9 million in 2023, then dropped by 5.19% to $390.6 million in 2024, then grew by 2.15% to $399.0 million in 2025, then advanced by 6.32% to $424.2 million in 2026.
• The last three Assets Average figures came in at $424.2 million (Q2 2026), $403.4 million (Q1 2026), and $399.0 million (Q4 2025), per Business Quant data.